Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening

Journal of Obstetrics and Gynaecology Research

Volumn 22, Issue 6, 1996, Pages 629-636

  Lörincz, Attila T ^a  

^a Digene Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER PREVENTION; DIAGNOSTIC TEST; DNA DETERMINATION; FEMALE; HUMAN; MASS SCREENING; PAPANICOLAOU TEST; REVIEW; UTERINE CERVIX CANCER; WART VIRUS; ARTICLE; IMMUNOASSAY; ISOLATION AND PURIFICATION; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; FEMALE; HUMANS; IMMUNOASSAY; MASS SCREENING; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030299969     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1996.tb01081.x     Document Type: Article

References (20)

1. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obst et Gynecol 1992; 79: 328-337
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, and International Biological Study on Cervical Cancer (IBSCC) Study-Group. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, J Natl Cancer Inst 1995; 87: 796-802
3. Morrison EAB, Ho GYF, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 1991; 49: 6-13
4. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 65: 5-27
5. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606
6. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kurman RJ, Kiviat NB, Stoler M, Glass AG, Rush BB. Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high risk human papillomavirus types. Am J Clin Pathol 1994; 102: 182-187
7. Reid R, Greenberg MD, Lorincz A, et al. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991; 164: 1461-1471
8. Wright TG, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995; 85: 202-210
9. Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papillomavirus testing for intermediate-and high-risk types as triage before colposcopy. Am J Obstet Gynecol 1995; 172: 1150-1157
10. Davis GL, Hernandez E, Davis JL, Miyazawa K, Atypical squamous cells in Papanicolaou smears. Obstet Gynecol 1987; 69: 43-46
11. Kurman RJ, Henson D, Herbst A, Noller K, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271: 1866-1869
12. Boring CC. Squires TS, Tong T. Cancer statistics, 1991. CA Cancer J Clin 1991; 41: 19-36
13. Pollard-Night D, Simmonds AC, Schaap AP, Akhavan H, Brady MAW. Non-radioactive DNA detection on Southern blots by enzymatically triggered chemiluminescence. Ann Biochem 1990; 185: 353-358
14. Goldsborough MD, McAllister P, Reid R, Temple G, Lorincz AT. A comparison of human papillomavirus prevalence by the polymerase chain reaction in low risk women and in a gynaecology referral group at elevated risk for cervical cancer. Mol Cell Probes 1992; 6: 451-457
15. Schiffman MY, Bauer HM, Lorincz AT, Manos MM, Byrne JC, Glass AG, Cadell DM, Howley PM. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991; 29: 573-577
16. Quint WGV, Heijtink RA, Schirm J, Gerlich WH, Niesters HGM. Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995; 33: 225-228
17. Noordhoek GT, Kolk AH, Bijune G, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: A blind comparison study among seven laboratories. J Clin Microbiol 1994; 32: 277-284
18. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appars to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-954
19. Hall S, Lorincz A, Shah F, Sherman ME, Abbas F, Paull G, Kurman RJ, Shah KV. Human papillomavirus DNA detection in cervical specimens by Hybrid Capture: Correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996; 62: 353-359
20. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol 1996; 175: 651-656